Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatic analysis of the obesity paradox and possible associated factors in colorectal cancer using TCGA cohorts. | J Cancer | 2023 | 36860923 | PubTator, text mining | PubMed |
| Homozygous Knockout of Cep250 Leads to a Relatively Late-Onset Retinal Degeneration and Sensorineural Hearing Loss in Mice. | Transl Vis Sci Technol | 2023 | 36857066 | PubTator, text mining | PubMed |
| Characterizing the genotypic spectrum of retinitis pigmentosa in East Asian populations: a systematic review. | Ophthalmic Genet | 2023 | 36856324 | PubTator, text mining | PubMed |
| Recombinant Pseudorabies Virus Usage in Vaccine Development against Swine Infectious Disease. | Viruses | 2023 | 36851584 | PubTator, text mining | PubMed |
| Preparation and Identification of a Monoclonal Antibody against the Pseudorabies Virus gE Glycoprotein through a Novel Strategy. | Vet Sci | 2023 | 36851437 | PubTator, text mining | PubMed |
| Psychometric Validation of the ViSIO-PRO and ViSIO-ObsRO in Retinitis Pigmentosa and Leber Congenital Amaurosis. | Ophthalmol Ther | 2023 | 36847938 | PubTator, text mining | PubMed |
| Identification of three metabolic subtypes in gastric cancer and the construction of a metabolic pathway-based risk model that predicts the overall survival of GC patients. | Front Genet | 2023 | 36845398 | PubTator, text mining | PubMed |
| Suppression of MR1 by human cytomegalovirus inhibits MAIT cell activation. | Front Immunol | 2023 | 36845106 | PubTator, text mining | PubMed |
| New insights from GWAS on BMI-related growth traits in a longitudinal cohort of admixed children with Native American and European ancestry. | iScience | 2023 | 36844456 | PubTator, text mining | PubMed |
| Integrating single-cell RNA-seq and bulk RNA-seq to construct prognostic signatures to explore the role of glutamine metabolism in breast cancer. | Front Endocrinol (Lausanne) | 2023 | 36843602 | PubTator, text mining | PubMed |
| Neutrophil Extracellular Traps and Their Possible Implications in Ocular Herpes Infection. | Pathogens | 2023 | 36839481 | PubTator, text mining | PubMed |
| Challenges and Opportunities in the Genetic Analysis of Inherited Retinal Dystrophies in Africa, a Literature Review. | J Pers Med | 2023 | 36836473 | PubTator, text mining | PubMed |
| Genetic Characteristics and Long-Term Follow-Up of Slovenian Patients with RPGR Retinal Dystrophy. | Int J Mol Sci | 2023 | 36835250 | PubTator, text mining | PubMed |
| Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 36834851 | PubTator, text mining | PubMed |
| Towards a Cure for HARS Disease. | Genes (Basel) | 2023 | 36833180 | PubTator, text mining | PubMed |
| Molecular Re-Diagnosis with Whole-Exome Sequencing Increases the Diagnostic Yield in Patients with Non-Syndromic Retinitis Pigmentosa. | Diagnostics (Basel) | 2023 | 36832217 | PubTator, text mining | PubMed |
| Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma. | Oxid Med Cell Longev | 2023 | 36825082 | PubTator, text mining | PubMed |
| Cost-effective sequence analysis of 113 genes in 1,192 probands with retinitis pigmentosa and Leber congenital amaurosis. | Front Cell Dev Biol | 2023 | 36819107 | PubTator, text mining | PubMed |
| Prognosis and personalized medicine prediction by integrated whole exome and transcriptome sequencing of hepatocellular carcinoma. | Front Genet | 2023 | 36816040 | PubTator, text mining | PubMed |
| Application of an angiogenesis-related genes risk model in lung adenocarcinoma prognosis and immunotherapy. | Front Genet | 2023 | 36816016 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=22